Literature DB >> 23789677

Abdominopelvic and lower extremity deep venous thrombosis: evaluation with contrast-enhanced MR venography with a blood-pool agent.

Steven Y Huang1, Charles Y Kim, Michael J Miller, Rajan T Gupta, Mark L Lessne, Jeffrey J Horvath, Daniel T Boll, Paul D Evans, Nicholas T Befera, Pranay Krishnan, Johanna L Chan, Elmar M Merkle.   

Abstract

OBJECTIVE: The purpose of this article is to evaluate contrast-enhanced (CE) MR venography (MRV) with a blood-pool agent for detection of abdominopelvic and lower extremity deep venous thrombosis (DVT) compared with a conventional unenhanced gradient-recalled echo (GRE) MRV technique.
MATERIALS AND METHODS: This retrospective study was performed on 30 patients (mean age, 52.7 years; 15 men and 15 women) referred for MRV between March 2010 and November 2010 for evaluation of lower extremity or abdominopelvic DVT. All patients underwent a GRE sequence followed by a CE T1-weighted sequence with gadofosveset, a blood-pool agent. The abdominopelvic and lower extremity venous system was divided into 13 segments. The presence of acute or chronic DVT was assessed by six radiologists, as well as qualitative and quantitative assessments of each venous segment. Image acquisition and interpretation times were also tabulated.
RESULTS: The sensitivity and specificity for acute DVT were 91.0% and 99.8%, respectively, on CE MRV compared with 80.8% and 95.8%, respectively, on GRE MRV (p = 0.077 and p < 0.001). The sensitivity and specificity for chronic DVT were 84.4% and 98.4%, respectively, on CE MRV and 64.5% and 95.6%, respectively, on GRE MRV (p < 0.001 for both). Subjective ratings of vein visualization, signal homogeneity, and confidence pertaining to DVT diagnosis were significantly higher with the CE images (p < 0.001). The contrast-to-noise ratio for CE images was similar or significantly higher for all venous segments. Image acquisition and radiologist interpretation times on the CE studies were decreased (p < 0.001).
CONCLUSION: Gadofosveset-enhanced MRV had equal or higher sensitivity and specificity for detection of DVT than did GRE MRV, with decreased time for image acquisition and interpretation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23789677     DOI: 10.2214/AJR.12.9611

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  10 in total

Review 1.  Lower extremity venous reflux.

Authors:  Vinit Baliyan; Shahein Tajmir; Sandeep S Hedgire; Suvranu Ganguli; Anand M Prabhakar
Journal:  Cardiovasc Diagn Ther       Date:  2016-12

Review 2.  Blood pool contrast agents for venous magnetic resonance imaging.

Authors:  Irai S Oliveira; Sandeep S Hedgire; Weier Li; Suvranu Ganguli; Anand M Prabhakar
Journal:  Cardiovasc Diagn Ther       Date:  2016-12

Review 3.  Use of Computed Tomography and Magnetic Resonance Imaging in Central Venous Disease.

Authors:  Justinas Silickas; Stephen A Black; Alkystis Phinikaridou; Adam M Gwozdz; Alberto Smith; Prakash Saha
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

Review 4.  Extracardiac applications of MR blood pool contrast agent in children.

Authors:  Shannon G Farmakis; Geetika Khanna
Journal:  Pediatr Radiol       Date:  2014-11-19

Review 5.  Advanced imaging in acute and chronic deep vein thrombosis.

Authors:  Gita Yashwantrao Karande; Sandeep S Hedgire; Yadiel Sanchez; Vinit Baliyan; Vishala Mishra; Suvranu Ganguli; Anand M Prabhakar
Journal:  Cardiovasc Diagn Ther       Date:  2016-12

6.  Pharmacological reduction of coagulation factor XI reduces macrophage accumulation and accelerates deep vein thrombosis resolution in a mouse model of venous thrombosis.

Authors:  Kelley R Jordan; Cory R Wyatt; Meghan E Fallon; Randy Woltjer; Edward A Neuwelt; Quifang Cheng; David Gailani; Christina Lorentz; Erik I Tucker; Owen J T McCarty; Monica T Hinds; Khanh P Nguyen
Journal:  J Thromb Haemost       Date:  2022-07-18       Impact factor: 16.036

7.  High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort.

Authors:  Anjali B Nayak; Aarti Luhar; Mark Hanudel; Barbara Gales; Theodore R Hall; J Paul Finn; Isidro B Salusky; Joshua Zaritsky
Journal:  Pediatr Nephrol       Date:  2014-09-12       Impact factor: 3.714

8.  Concomitant chronic venous insufficiency in patients with peripheral artery disease: insights from MR angiography.

Authors:  Felix Ammermann; Felix G Meinel; Ebba Beller; Anke Busse; Felix Streckenbach; Christine Teichert; Malte Weinrich; Andreas Neumann; Marc-André Weber; Thomas Heller
Journal:  Eur Radiol       Date:  2020-02-25       Impact factor: 5.315

9.  DANTE-SPACE: a new technical tool for DVT on 1.5T MRI.

Authors:  Gaoming Zhuang; Caiyun Tang; Xueping He; Jianke Liang; Zhuonan He; Yufeng Ye; Wei Deng; Dexiang Liu; Hanwei Chen
Journal:  Int J Cardiovasc Imaging       Date:  2019-08-24       Impact factor: 2.357

10.  Cardiovascular magnetic resonance black-blood thrombus imaging for the diagnosis of acute deep vein thrombosis at 1.5 Tesla.

Authors:  Hanwei Chen; Xueping He; Guoxi Xie; Jianke Liang; Yufeng Ye; Wei Deng; Zhuonan He; Dexiang Liu; Debiao Li; Xin Liu; Zhaoyang Fan
Journal:  J Cardiovasc Magn Reson       Date:  2018-06-25       Impact factor: 5.364

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.